Accessibility Menu
Cann Group logo

Cann Group(OTC) CNGGF

Market Cap$5.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-99%
1 Year-66%
1 Month-13%
$0.00
+0%
+0.00Today
Cann Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-06-18
Cann Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-13.79%USD 0.002026-06-09
1 month-12.82%USD 0.002026-04-27
3 month-46.03%USD 0.012026-03-17
Year to date-43.8%USD 0.012025-12-26
1 year-66%USD 0.012025-06-12
3 year-96.83%USD 0.112023-06-13
5 year-98.87%USD 0.302021-06-18
Since inception-99.86%USD 2.432017-12-04

Cann Group Financials at a Glance

Market Cap

$5.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$26.81M

Net Income (TTM)

-A$32.88M

EPS (TTM)

$0.01

P/E Ratio

0.42

Dividend

$0.00

Beta (Volatility)

8.14 (High)

Price

$0.00

Volume

300

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Aug 24, 2026

CNGGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cann Group

Cann Group Limited specializes in the end-to-end process of bringing medicinal cannabis to market. The company engages in genetic development, cultivation, product manufacturing, clinical trials, and the supply of therapeutic cannabis for both Australian and international markets.

Products and Services
  • Medicinal cannabis products for therapeutic use
  • Research and development in cannabis cultivation
  • Clinical trials for cannabis-based therapies
Growth Outlook
  • Significant increase in revenue to AUD 4.5 million in the latest quarter
  • Expansion into international markets expected to drive future growth
  • Strong demand for medicinal cannabis products in Australia
Financial Highlights
  • Trailing twelve months revenue of AUD 6.8 million
  • Net income of AUD 26.4 million reported in the latest quarter
  • Current ratio of 0.42 indicates liquidity challenges
Cann Group Limited operates in the healthcare sector, focusing on the rapidly growing medicinal cannabis industry. The company has shown promising revenue growth, with a notable increase in the latest quarter, reflecting strong market demand. However, the current ratio suggests potential liquidity challenges that may need to be addressed. The company's strategic focus on research and development, along with its commitment to clinical trials, positions it well for future growth in both domestic and international markets. Investors may find Cann Group Limited an intriguing opportunity within the specialty drug manufacturing industry.
AI Generated • Jul 23, 2026

Industry

Pharmaceuticals

CEO

Jennifer Lee Pilcher

Headquarters

Port Melbourne, VIC 3207, AU

CNGGF Financials

Key Financial Metrics (TTM)

Gross Margin

-20.82%

Operating Margin

-97.39%

Net Income Margin

130.29%

Return on Equity

93.89%

Return on Capital

-12.24%

Return on Assets

26.52%

Earnings Yield

2.38%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.66B

Volume

300

Avg. Volume

16.42K

Financials (TTM)

Gross Profit

A$2.57M

Operating Income

-A$20.44M

EBITDA

-A$16.80M

Operating Cash Flow

-A$18.77M

Capital Expenditure

-A$441.96K

Free Cash Flow

-A$19.21M

Cash & ST Invst.

A$954.62K

Total Debt

A$15.10M

Cann Group Performance Analysis

Cann Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 4,649,807N/A
20232023-06-30AUD 9,267,85099.3%
20242024-06-30AUD 10,075,0808.7%
20252025-06-30AUD 7,318,230-27.4%
Cann Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-3.0%
Q22024-12-31-28.5%
Q42025-06-304.9%
Q22025-12-31-33.4%
Cann Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.05N/A
20232023-06-30AUD -0.067.4%
20242024-06-30AUD -0.0728.0%
20252025-06-30AUD -0.03-63.0%
Cann Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-147.9%
Q22024-12-3173.5%
Q42025-06-309.4%
Q22025-12-31255.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$4.52M

-51.5%

Gross Profit

-A$4.46M

+51.8%

Gross Margin

-98.63%

N/A

Market Cap

$5.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$57.61K

N/A

Employees

98

N/A

Net Income

A$26.37M

+283.9%

EBITDA

-A$2.49M

+69.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$954.62K

-41.6%

Total Debt

A$15.10M

-76.9%

Accounts Receivable

A$867.66K

-35.1%

Inventory

A$6.47M

-47.8%

Long Term Debt

A$156.94K

N/A

Short Term Debt

A$14.94M

-77.1%

Return on Assets

26.52%

N/A

Return on Invested Capital

-31.90%

N/A

Free Cash Flow

-A$114.95K

+98.6%

Operating Cash Flow

-A$11.00K

+99.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AVTBFAvant Brands Inc.
$0.39+2.23%
CPIVFCaptiva Verde Wellness Corp.
$0.02+0.00%
RVVTFRevive Therapeutics Ltd.
$0.02+0.00%
LIFDLFTD Partners Inc.
$0.20+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
SKHYSK Hynix
$126.79-0.03%
NOKNokia
$8.41-0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About CNGGF

What is the current price of Cann Group?

Cann Group is trading at $0.00 per share.

What is the 52-week range for Cann Group?

Over the past 52 weeks, Cann Group has traded between $0.00 and $0.02.

How much debt does Cann Group have?

As of the most recent reporting period, Cann Group reported total debt of A$49.92M.

How much cash does Cann Group have on hand?

Cann Group reported A$6.55K in cash and cash equivalents in its most recent financial results.

What is Cann Group’s dividend yield?

Cann Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.